In a meta-analysis which encompassed 15 types of cancers including diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM), and CLL, high MALAT1 expression was found to be a good prognostic factor for OS in B-cell neoplasms [29]. This evidence concerns the gene MALAT1 and B-cell neoplasm.